國家衛生研究院 NHRI:Item 3990099045/13489

NHRI > Institute of Biotechnology and Pharmaceutical Research > Chun-Ping Chang > Periodical Articles > Item 3990099045/13489

Please use this identifier to cite or link to this item: http://ir.nhri.org.tw/handle/3990099045/13489

Title:	Synergistic inhibition of SARS-CoV-2 replication using disulfiram/ebselen and remdesivir[Erratum:ACS Pharmacology and Translational Science. 2021 Apr 9;4(2):898-907.]
Other Titles:	Correction to ";Synergistic Inhibition of SARS-CoV-2 Replication Using Disulfiram/Ebselen and Remdesivir"
Authors:	Chen, T;Fei, CY;Chen, YP;Sargsyan, K;Liang, JJ;Liao, CC;Lin, YL;Chang, CP;Yuan, HS;Lim, C
Contributors:	Institute of Biotechnology and Pharmaceutical Research
Abstract:	In the original manuscript, the authors Jian-Jong Liang, Chun-Che Liao, and Yi-Ling Lin were not listed. These three authors had performed the cell-based experiments in Figure 5b,c but were mistakenly listed in the acknowledgment section. The author list and affiliations should appear as in this Correction.
Date:	2021-06-11
Relation:	ACS Pharmacology and Translational Science. 2021 Jun 11;4(3):Article number 1246.
Link to:	http://dx.doi.org/10.1021/acsptsci.1c00106
Cited Times(Scopus):	https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85106586861
Appears in Collections:	[Chun-Ping Chang] Periodical Articles

Files in This Item:

File	Description	Size	Format
PUB34136759.pdf		568Kb	Adobe PDF	88	View/Open